Skip to main content
Erschienen in: Inflammation 6/2011

01.12.2011

Effect of N-Acetylcysteine and Fructose-1,6-Bisphosphate in the Treatment of Experimental Sepsis

verfasst von: Ricardo Obalski de Mello, Adroaldo Lunardelli, Eduardo Caberlon, Cristina Machado Bragança de Moraes, Roberto Christ Vianna Santos, Vinicius Lorini da Costa, Gabriela Viegas da Silva, Patrícia da Silva Scherer, Luiz Eduardo Coimbra Buaes, Denizar Alberto da Silva Melo, Márcio Vinícius Fagundes Donadio, Fernanda Bordignon Nunes, Jarbas Rodrigues de Oliveira

Erschienen in: Inflammation | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Sepsis is a syndrome caused by uncontrolled systemic inflammatory response of the individual, which represents a serious epidemiological problem worldwide. The aim of this study was to investigate the effect of N-acetylcysteine (NAC) and fructose-1,6-bisphosphate (FBP) in the treatment of experimental sepsis. We used rats that were divided into five experimental groups: normal control (not induced), septic control (induced using a capsule with non sterile fecal content and Escherichia coli), treated with FBP (500 mg/kg i.p.), treated with NAC (150 mg/kg i.p.), and treated with the combination of FBP with NAC. In the group treated with NAC, 16.68% of the mice survived, the FBP reduced the mortality of mice during the acute stage of the disease and increased the animals’ survival time in 33.34%, and the combination of drugs had no effect. Our results show that NAC prevented the mortality of animals after septic induction. These data confirm the validity of the use of NAC in the treatment of sepsis. Our data also show that the synergistic action with FBP does not improve the picture.
Literatur
1.
Zurück zum Zitat Bone, R.C. 1991. The pathogenesis of sepsis. Annals of Internal Medicine 115: 457–469.PubMed Bone, R.C. 1991. The pathogenesis of sepsis. Annals of Internal Medicine 115: 457–469.PubMed
2.
3.
Zurück zum Zitat Bochud, P.Y., and T. Calandra. 2003. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 326: 262–266.PubMedCrossRef Bochud, P.Y., and T. Calandra. 2003. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 326: 262–266.PubMedCrossRef
4.
Zurück zum Zitat Martin, G.S., D.M. Mannino, S. Eaton, et al. 2003. Epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine 348: 1546–1554.PubMedCrossRef Martin, G.S., D.M. Mannino, S. Eaton, et al. 2003. Epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine 348: 1546–1554.PubMedCrossRef
5.
Zurück zum Zitat Silva, E., A. Pedro Mde, A.C. Sogayar, T. Mohovic, C.L. Silva, M. Janiszewski, R.G. Cal, E.F. Sousa, T.P. Abe, J. Andrade, J.D. Matos, E. Rezende, M. Assunção, A. Avezum, P.C. Rocha, G.F. Matos, A.M. Bento, A.D. Corrêa, P.C. Vieira, and E. Knobel. 2004. Brazilian Sepsis Epidemiological Study. Critical Care 8(4): 251–260.CrossRef Silva, E., A. Pedro Mde, A.C. Sogayar, T. Mohovic, C.L. Silva, M. Janiszewski, R.G. Cal, E.F. Sousa, T.P. Abe, J. Andrade, J.D. Matos, E. Rezende, M. Assunção, A. Avezum, P.C. Rocha, G.F. Matos, A.M. Bento, A.D. Corrêa, P.C. Vieira, and E. Knobel. 2004. Brazilian Sepsis Epidemiological Study. Critical Care 8(4): 251–260.CrossRef
6.
Zurück zum Zitat Hinshaw, L.B. 1996. Sepsis/Septic shock: participation of the microcirculation: Na abbreviated review. Critical Care Medicine 24: 1072–1078.PubMedCrossRef Hinshaw, L.B. 1996. Sepsis/Septic shock: participation of the microcirculation: Na abbreviated review. Critical Care Medicine 24: 1072–1078.PubMedCrossRef
7.
Zurück zum Zitat Creteur, J., and J.L. Vicente. 2000. Hemoglobin solutions: an “all-in-one” therapeutic strategy in sepsis? Critical Care Medicine 28: 894–896.PubMedCrossRef Creteur, J., and J.L. Vicente. 2000. Hemoglobin solutions: an “all-in-one” therapeutic strategy in sepsis? Critical Care Medicine 28: 894–896.PubMedCrossRef
8.
Zurück zum Zitat Thijs, L.G., et al. 1995. Time course of citokine levels in sepsis. Intensive Care Medicine 21: S258–S263.PubMedCrossRef Thijs, L.G., et al. 1995. Time course of citokine levels in sepsis. Intensive Care Medicine 21: S258–S263.PubMedCrossRef
9.
Zurück zum Zitat Davies, M.G., and P.O. Hagen. 1997. Systemic inflammatory response syndrome. The British Journal of Surgery 84(7): 920–935.PubMedCrossRef Davies, M.G., and P.O. Hagen. 1997. Systemic inflammatory response syndrome. The British Journal of Surgery 84(7): 920–935.PubMedCrossRef
10.
Zurück zum Zitat Rubanyi, G.M. 1996. Fatores derivados do endotélio no choque. Clin Bras Med Intensiva 3: 13–26. Rubanyi, G.M. 1996. Fatores derivados do endotélio no choque. Clin Bras Med Intensiva 3: 13–26.
11.
Zurück zum Zitat Groeneveld, A.B.C., A.D.M. Kester, and J.J.P. Nauta. 1987. Relation of arterial blood lactate to oxygen delivery and hemodynamic variables in human shock states. Circulatory Shock 22: 35–53.PubMed Groeneveld, A.B.C., A.D.M. Kester, and J.J.P. Nauta. 1987. Relation of arterial blood lactate to oxygen delivery and hemodynamic variables in human shock states. Circulatory Shock 22: 35–53.PubMed
12.
Zurück zum Zitat Metrangolo, L., M. Fiorillo, G. Friedman, et al. 1995. Early hemodynamic course of septic shock. Critical Care Medicine 23: 1931–1975.CrossRef Metrangolo, L., M. Fiorillo, G. Friedman, et al. 1995. Early hemodynamic course of septic shock. Critical Care Medicine 23: 1931–1975.CrossRef
13.
Zurück zum Zitat Benjamin, E., A.B. Leibowitz, J. Oropello, and T.J. Iberti. 1992. Systemic hypoxic and inflammatory syndrome: an alternative designation for “sepsis syndrome”. Critical Care Medicine 20: 680–682.PubMedCrossRef Benjamin, E., A.B. Leibowitz, J. Oropello, and T.J. Iberti. 1992. Systemic hypoxic and inflammatory syndrome: an alternative designation for “sepsis syndrome”. Critical Care Medicine 20: 680–682.PubMedCrossRef
14.
Zurück zum Zitat Azevedo, L.C., M. Janiszewski, F.G. Sorino, and F.R. Laurino. 2006. Redox mechanisms of vascular cell dysfunction in sepsis. Endocrine, Metabolic & Immune Disorders Drug Targets 6: 159–164. Azevedo, L.C., M. Janiszewski, F.G. Sorino, and F.R. Laurino. 2006. Redox mechanisms of vascular cell dysfunction in sepsis. Endocrine, Metabolic & Immune Disorders Drug Targets 6: 159–164.
15.
Zurück zum Zitat Halliwell, B., and J.M.C. Gutteridge. 1999. Free radicals in biology and medicine, 3rd ed. New York: Oxford University Press. Halliwell, B., and J.M.C. Gutteridge. 1999. Free radicals in biology and medicine, 3rd ed. New York: Oxford University Press.
16.
Zurück zum Zitat Dalle-Donne, I., G. Aldini, M. Carini, R. Colombo, R. Rossi, and A. Milzani. 2006. Protein carbonylation, cellular dysfunction and disease progression. Journal of Cellular and Molecular Medicine 10(2): 389–406.PubMedCrossRef Dalle-Donne, I., G. Aldini, M. Carini, R. Colombo, R. Rossi, and A. Milzani. 2006. Protein carbonylation, cellular dysfunction and disease progression. Journal of Cellular and Molecular Medicine 10(2): 389–406.PubMedCrossRef
17.
Zurück zum Zitat Carvalho, P.R.A., and E.A. Trotta. 2003. Avanços no diagnóstico e tratamento da sepse. Jornal de Pediatria 79(2): S195–S204.PubMedCrossRef Carvalho, P.R.A., and E.A. Trotta. 2003. Avanços no diagnóstico e tratamento da sepse. Jornal de Pediatria 79(2): S195–S204.PubMedCrossRef
18.
Zurück zum Zitat Aiub, C.A.F., R. Bortolini, and A.A. Azambuja. 2003. Alves Filho JCF, Nunes FB, Oliveira JR. Alterations in the indexes of apoptosis and necrosis induced by galactosamine in the liver of Wistar rats treated with fructose-1, 6-bisphosphate. Hepatology Research 25(1): 83–91.CrossRef Aiub, C.A.F., R. Bortolini, and A.A. Azambuja. 2003. Alves Filho JCF, Nunes FB, Oliveira JR. Alterations in the indexes of apoptosis and necrosis induced by galactosamine in the liver of Wistar rats treated with fructose-1, 6-bisphosphate. Hepatology Research 25(1): 83–91.CrossRef
19.
Zurück zum Zitat Oliveira, J.R., J.L. Rosa, S. Ambrosio, et al. 1992. Effect of galactosamine on hepatic carbohydrate metabolism: protective role of fructose-1, 6-bisphosphate. Hepatology 15: 1147–1153.PubMedCrossRef Oliveira, J.R., J.L. Rosa, S. Ambrosio, et al. 1992. Effect of galactosamine on hepatic carbohydrate metabolism: protective role of fructose-1, 6-bisphosphate. Hepatology 15: 1147–1153.PubMedCrossRef
20.
Zurück zum Zitat Nunes, F.B., and C.M. Graziottin. 2003. Alves Filho JCF, Lunardelli A, Pires MGS, Wächter PH, Oliveira JR. An assessment of fructose-1, 6-bisphosphate as an antimicrobial and anti-inflammatory agent in sepsis. Pharmacological Research 47(1): 35–41.PubMedCrossRef Nunes, F.B., and C.M. Graziottin. 2003. Alves Filho JCF, Lunardelli A, Pires MGS, Wächter PH, Oliveira JR. An assessment of fructose-1, 6-bisphosphate as an antimicrobial and anti-inflammatory agent in sepsis. Pharmacological Research 47(1): 35–41.PubMedCrossRef
21.
Zurück zum Zitat Cattani, L., R. Costrini, C. Cerilli, M.P. Rigobello, M. Bianchi, and L. Galzigna. 1980. Fructose-1, 6-diphosphate dependence on the toxicity and uptake of potassium ions. Agressologie 21: 263–264.PubMed Cattani, L., R. Costrini, C. Cerilli, M.P. Rigobello, M. Bianchi, and L. Galzigna. 1980. Fructose-1, 6-diphosphate dependence on the toxicity and uptake of potassium ions. Agressologie 21: 263–264.PubMed
22.
Zurück zum Zitat Sola, A., J. Panes, C. Xaus, and G. Hotter. 2003. Fructose-1, 6-biphosphate and nucleoside pool modifications prevent neutrophil accumulation in the reperfused intestine. Journal of Leukocyte Biology 73: 74–81.PubMedCrossRef Sola, A., J. Panes, C. Xaus, and G. Hotter. 2003. Fructose-1, 6-biphosphate and nucleoside pool modifications prevent neutrophil accumulation in the reperfused intestine. Journal of Leukocyte Biology 73: 74–81.PubMedCrossRef
23.
Zurück zum Zitat Nunes, F.B., C.M. Graziottin, J.C.F. Alves-Filho, A. Lunardelli, E. Caberlon, A. Peres, and J.R. Rodrigues. 2003. Immunomodulatory effect of fructose-1, 6-bisphosphate on T-lymphocytes. International Immunopharmacology 3: 267–272.CrossRef Nunes, F.B., C.M. Graziottin, J.C.F. Alves-Filho, A. Lunardelli, E. Caberlon, A. Peres, and J.R. Rodrigues. 2003. Immunomodulatory effect of fructose-1, 6-bisphosphate on T-lymphocytes. International Immunopharmacology 3: 267–272.CrossRef
24.
Zurück zum Zitat Nunes, F.B., and M.G.S. Pires. 2002. Alves Filho JCF, Wachter PH, Oliveira JR. Physiopathological studies in septic rats and the use of fructose-1, 6-bisphosphate as cellular protection. Critical Care Medicine 30: 2069–2074.PubMedCrossRef Nunes, F.B., and M.G.S. Pires. 2002. Alves Filho JCF, Wachter PH, Oliveira JR. Physiopathological studies in septic rats and the use of fructose-1, 6-bisphosphate as cellular protection. Critical Care Medicine 30: 2069–2074.PubMedCrossRef
25.
Zurück zum Zitat Pinho, R.A., P.C.L. Silveira, L.A. Silva, E.L. Streck, F. Dal-Pizzol, and J.C.F. Moreira. 2005. N-acetycysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure. Environmental Research 99: 355–360.PubMedCrossRef Pinho, R.A., P.C.L. Silveira, L.A. Silva, E.L. Streck, F. Dal-Pizzol, and J.C.F. Moreira. 2005. N-acetycysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure. Environmental Research 99: 355–360.PubMedCrossRef
26.
Zurück zum Zitat Reed, D.J., and M.W. Fariss. 1984. Glutathione depletion and susceptibility. Pharmacological Reviews 36: 25S–33S.PubMed Reed, D.J., and M.W. Fariss. 1984. Glutathione depletion and susceptibility. Pharmacological Reviews 36: 25S–33S.PubMed
27.
Zurück zum Zitat Heyman, S.N., M. Goldfarb, A. Shina, F. Karmeli, and S. Rosen. 2003. N-acetylcysteine ameliorates renal microcirculation: studies in rats. Kidney International 63(2): 634–641.PubMedCrossRef Heyman, S.N., M. Goldfarb, A. Shina, F. Karmeli, and S. Rosen. 2003. N-acetylcysteine ameliorates renal microcirculation: studies in rats. Kidney International 63(2): 634–641.PubMedCrossRef
28.
Zurück zum Zitat Prescott, L.F., R.N. Illingworth, J.A. Critchley, M.J. Stewart, R.D. Adam, and A.T. Proudfoot. 1979. Intravenous n-acetylcysteine: the treatment of choice for paracetamol poisoning. British Medical Journal 2: 1097–1100.PubMedCrossRef Prescott, L.F., R.N. Illingworth, J.A. Critchley, M.J. Stewart, R.D. Adam, and A.T. Proudfoot. 1979. Intravenous n-acetylcysteine: the treatment of choice for paracetamol poisoning. British Medical Journal 2: 1097–1100.PubMedCrossRef
29.
Zurück zum Zitat Miquel, J., M.L. Ferrandiz, E. De Juan, I. Sevila, and M. Martinez. 1995. N-acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria. European Journal of Pharmacology 292: 333–335.PubMed Miquel, J., M.L. Ferrandiz, E. De Juan, I. Sevila, and M. Martinez. 1995. N-acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria. European Journal of Pharmacology 292: 333–335.PubMed
30.
Zurück zum Zitat Ritter, C., M.E. Andrades, A. Reinke, S. Menna-Barreto, J.C. Moreira, and F. Dal-Pizzol. 2004. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Critical Care Medicine 32: 342–349.PubMedCrossRef Ritter, C., M.E. Andrades, A. Reinke, S. Menna-Barreto, J.C. Moreira, and F. Dal-Pizzol. 2004. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Critical Care Medicine 32: 342–349.PubMedCrossRef
31.
Zurück zum Zitat Nunes, F.B., J.R. Oliveira, M.G.S. Pires, and P.H. Wächter. 2000. Septic induction in rats (Wistar): experimental model. Revista de Medicina da PUCRS 10: 183–187. Nunes, F.B., J.R. Oliveira, M.G.S. Pires, and P.H. Wächter. 2000. Septic induction in rats (Wistar): experimental model. Revista de Medicina da PUCRS 10: 183–187.
32.
Zurück zum Zitat Buege, J.A., and S.D. Aust. 1978. Microsomal Lipid Peroxidation. Methods Enzymology 52: 302–310.CrossRef Buege, J.A., and S.D. Aust. 1978. Microsomal Lipid Peroxidation. Methods Enzymology 52: 302–310.CrossRef
33.
Zurück zum Zitat Boveris, A., C.G. Fraga, A.I. Varsavsks, and O.R. Koch. 1983. Archives of Biochemistry and Biophysics 227: 534–541.PubMedCrossRef Boveris, A., C.G. Fraga, A.I. Varsavsks, and O.R. Koch. 1983. Archives of Biochemistry and Biophysics 227: 534–541.PubMedCrossRef
35.
Zurück zum Zitat Faure, P., and J.L. Lafond. 1995. Measurement of sulphydryl and carbonyl groups as a possible indicator of protein oxidation. Analysis of free radicals in biological systems. Boston: Verlag. Faure, P., and J.L. Lafond. 1995. Measurement of sulphydryl and carbonyl groups as a possible indicator of protein oxidation. Analysis of free radicals in biological systems. Boston: Verlag.
36.
Zurück zum Zitat Vandijck, D., J.M. Decruyenaere, and S.I. Blot. 2006. The value of sepsis definitions in daily ICU-practice. Acta Clinica Belgica 61(5): 220–226.PubMed Vandijck, D., J.M. Decruyenaere, and S.I. Blot. 2006. The value of sepsis definitions in daily ICU-practice. Acta Clinica Belgica 61(5): 220–226.PubMed
37.
Zurück zum Zitat Rudiger, A., M. Stotz, and M. Singer. 2008. Cellular processes in sepsis. Swiss Medical Weekly 138: 629–634.PubMed Rudiger, A., M. Stotz, and M. Singer. 2008. Cellular processes in sepsis. Swiss Medical Weekly 138: 629–634.PubMed
38.
Zurück zum Zitat Dunn, L.L., Y.S. Rahmanto, and D.R. Richardson. 2007. Iron uptake and metabolism in the new millennium. Trends in Cell Biology 17(2): 93–100.PubMedCrossRef Dunn, L.L., Y.S. Rahmanto, and D.R. Richardson. 2007. Iron uptake and metabolism in the new millennium. Trends in Cell Biology 17(2): 93–100.PubMedCrossRef
39.
Zurück zum Zitat Cooper, J.M., and A.H. Schapira. 2007. Friedreich’s ataxia: coenzyme Q10 andvitamin E therapy. Mitochondrion 7(Suppl1): S127–135.PubMedCrossRef Cooper, J.M., and A.H. Schapira. 2007. Friedreich’s ataxia: coenzyme Q10 andvitamin E therapy. Mitochondrion 7(Suppl1): S127–135.PubMedCrossRef
40.
Zurück zum Zitat Barichello, T., J.J. Fortunato, A.M. Vitali, G. Feier, A. Reinke, J.C. Moreira, J. Quevedo, and F. Dal-Pizzol. 2006. Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation. Critical Care Medicine 34: 886–889.PubMedCrossRef Barichello, T., J.J. Fortunato, A.M. Vitali, G. Feier, A. Reinke, J.C. Moreira, J. Quevedo, and F. Dal-Pizzol. 2006. Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation. Critical Care Medicine 34: 886–889.PubMedCrossRef
41.
Zurück zum Zitat Burdman, E. 1997. Epidemiologia. In IRA, insuficiência renal aguda: fisiopatologia, clínica e tratamento, ed. N. Schor, M.A. Boim, and O.F.P. Santos. São Paulo: Sarvier. Burdman, E. 1997. Epidemiologia. In IRA, insuficiência renal aguda: fisiopatologia, clínica e tratamento, ed. N. Schor, M.A. Boim, and O.F.P. Santos. São Paulo: Sarvier.
42.
Zurück zum Zitat Salvemini, D., and S. Cuzzocrea. 2003. Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine. Critical Care Medicine 31: S29–S38.PubMedCrossRef Salvemini, D., and S. Cuzzocrea. 2003. Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine. Critical Care Medicine 31: S29–S38.PubMedCrossRef
43.
Zurück zum Zitat Thiemermann, C. 2003. Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation. Critical Care Medicine 31: S76–S84.PubMedCrossRef Thiemermann, C. 2003. Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation. Critical Care Medicine 31: S76–S84.PubMedCrossRef
44.
Zurück zum Zitat Sprong, R.C., A.M.L. Winkelhuyzen-Janssen, C.J.M. Aarsman, J.F. Oirschot, T. Bruggen, and B.S. Asbeck. 1998. Low-dose Nacetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. American Journal of Respiratory and Critical Care Medicine 157: 1283–1293.PubMed Sprong, R.C., A.M.L. Winkelhuyzen-Janssen, C.J.M. Aarsman, J.F. Oirschot, T. Bruggen, and B.S. Asbeck. 1998. Low-dose Nacetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. American Journal of Respiratory and Critical Care Medicine 157: 1283–1293.PubMed
45.
Zurück zum Zitat Brown, G.C., and V. Borutaite. 2004. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochimica et Biophysica Acta 1658: 44–49.PubMedCrossRef Brown, G.C., and V. Borutaite. 2004. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochimica et Biophysica Acta 1658: 44–49.PubMedCrossRef
46.
Zurück zum Zitat Levy, M.M., M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S.M. Opal, J.L. Vincent, and G. Ramsay. 2003. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 31(4): 1250–1256.PubMedCrossRef Levy, M.M., M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S.M. Opal, J.L. Vincent, and G. Ramsay. 2003. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 31(4): 1250–1256.PubMedCrossRef
47.
Zurück zum Zitat Oliveira, L.M., M.G.S. Pires, A.B. Magrisso, T.P. Munhoz, R. Roesler, and J.R. Oliveira. 2009. Fructose-1, 6-bisphosphate inhibits in vitro and ex vivo platelet aggregation induced by ADP and ameliorates coagulation alterations in experimental sepsis in rats. Journal of Thrombosis and Thrombolysis 29: 387–394.PubMedCrossRef Oliveira, L.M., M.G.S. Pires, A.B. Magrisso, T.P. Munhoz, R. Roesler, and J.R. Oliveira. 2009. Fructose-1, 6-bisphosphate inhibits in vitro and ex vivo platelet aggregation induced by ADP and ameliorates coagulation alterations in experimental sepsis in rats. Journal of Thrombosis and Thrombolysis 29: 387–394.PubMedCrossRef
48.
Zurück zum Zitat Andrade, S.C., C. Dezoti, C.A. Shibuya, M. Watanabe, and M.F.F. Vattimo. 2004. Insuficiência Renal Aguda Isquêmica: Efeitos Comparativos do Alopurinol e N-Acetilcisteína como antioxidantes. Jornal Brasileiro De Nefrologia 26(2): 69–75. Andrade, S.C., C. Dezoti, C.A. Shibuya, M. Watanabe, and M.F.F. Vattimo. 2004. Insuficiência Renal Aguda Isquêmica: Efeitos Comparativos do Alopurinol e N-Acetilcisteína como antioxidantes. Jornal Brasileiro De Nefrologia 26(2): 69–75.
49.
Zurück zum Zitat Pereira-Filho, G., C. Ferreira, A. Schwengber, C. Marroni, C. Zettler, and N. Marroni. 2008. Role of N-acetylcysteine on fibrosis and oxidative stress in cirrhotic rats. Arquivos de Gastroenterologia 45(2): 156–162.PubMedCrossRef Pereira-Filho, G., C. Ferreira, A. Schwengber, C. Marroni, C. Zettler, and N. Marroni. 2008. Role of N-acetylcysteine on fibrosis and oxidative stress in cirrhotic rats. Arquivos de Gastroenterologia 45(2): 156–162.PubMedCrossRef
50.
Zurück zum Zitat Power, H.M., H.V. Heese, D.W. Beatty, J. Hughes, and W.S. Dempster. 1991. Iron fortification of infant milk formula: the effect on iron status and immune function. Annals of Tropical Paediatrics 11: 57–66.PubMed Power, H.M., H.V. Heese, D.W. Beatty, J. Hughes, and W.S. Dempster. 1991. Iron fortification of infant milk formula: the effect on iron status and immune function. Annals of Tropical Paediatrics 11: 57–66.PubMed
51.
Zurück zum Zitat Souza, R.L., and R.C.M. Succi. 1996. Oligoelementos e Infecção. Pediatria Moderna 31: 660–667. Souza, R.L., and R.C.M. Succi. 1996. Oligoelementos e Infecção. Pediatria Moderna 31: 660–667.
52.
Zurück zum Zitat Kent, S., E.D. Weinberg, and P. Stuart-Macadam. 1994. The etiology of the anemia of chronic disease and infection. Journal of Clinical Epidemiology 47: 23–33.PubMedCrossRef Kent, S., E.D. Weinberg, and P. Stuart-Macadam. 1994. The etiology of the anemia of chronic disease and infection. Journal of Clinical Epidemiology 47: 23–33.PubMedCrossRef
53.
Zurück zum Zitat Cançado, R.D., and C.S. Chiattone. 2002. Anemia de doença crônica. Revista Brasileira de Hematologia e Hemoterapia 4: 127–136. Cançado, R.D., and C.S. Chiattone. 2002. Anemia de doença crônica. Revista Brasileira de Hematologia e Hemoterapia 4: 127–136.
54.
Zurück zum Zitat Beaumont, C., and S. Vailont. 2006. Iron homeostasis. In Disorders of iron homeostasis, erythrocytes, erythropoiesis, ed. C. Beaumont, P. Beris, Y. Beuzard, and C. Brugnara. Genova: Forum Service Editore. Beaumont, C., and S. Vailont. 2006. Iron homeostasis. In Disorders of iron homeostasis, erythrocytes, erythropoiesis, ed. C. Beaumont, P. Beris, Y. Beuzard, and C. Brugnara. Genova: Forum Service Editore.
55.
Zurück zum Zitat Garcia Branco, R., R.C. Tasker, P.C. Ramos Garcia, J.P. Piva, and L. Dias Xavier. 2007. Glycemic control and insulin therapy in sepsis and critical illness. Jornal de Pediatria 83(5): S128–136.PubMedCrossRef Garcia Branco, R., R.C. Tasker, P.C. Ramos Garcia, J.P. Piva, and L. Dias Xavier. 2007. Glycemic control and insulin therapy in sepsis and critical illness. Jornal de Pediatria 83(5): S128–136.PubMedCrossRef
56.
Zurück zum Zitat Bowler, R.P., M. Nicks, K. Tran, et al. 2004. Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic in-flammation. American Journal of Respiratory Cell and Molecular Biology 31: 432–439.PubMedCrossRef Bowler, R.P., M. Nicks, K. Tran, et al. 2004. Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic in-flammation. American Journal of Respiratory Cell and Molecular Biology 31: 432–439.PubMedCrossRef
57.
Zurück zum Zitat Bowler, R.P., and J.D. Crapo. 2002. Oxidative stress in airways: Is there a role for extracellular superoxide dismutase? American Journal of Respiratory and Critical Care Medicine 166: S38–S43.PubMedCrossRef Bowler, R.P., and J.D. Crapo. 2002. Oxidative stress in airways: Is there a role for extracellular superoxide dismutase? American Journal of Respiratory and Critical Care Medicine 166: S38–S43.PubMedCrossRef
58.
Zurück zum Zitat Ritter, C., A.A. Cunha, I.C. Echer, M. Andrades, A. Reinke, N. Lucchiari, J. Rocha, E.L. Streck, S. Menna-Barreto, J.C.F. Moreira, and F. Dal-Pizzol. 2006. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Critical Care Medicine 34: 471–477.PubMedCrossRef Ritter, C., A.A. Cunha, I.C. Echer, M. Andrades, A. Reinke, N. Lucchiari, J. Rocha, E.L. Streck, S. Menna-Barreto, J.C.F. Moreira, and F. Dal-Pizzol. 2006. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Critical Care Medicine 34: 471–477.PubMedCrossRef
Metadaten
Titel
Effect of N-Acetylcysteine and Fructose-1,6-Bisphosphate in the Treatment of Experimental Sepsis
verfasst von
Ricardo Obalski de Mello
Adroaldo Lunardelli
Eduardo Caberlon
Cristina Machado Bragança de Moraes
Roberto Christ Vianna Santos
Vinicius Lorini da Costa
Gabriela Viegas da Silva
Patrícia da Silva Scherer
Luiz Eduardo Coimbra Buaes
Denizar Alberto da Silva Melo
Márcio Vinícius Fagundes Donadio
Fernanda Bordignon Nunes
Jarbas Rodrigues de Oliveira
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 6/2011
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-010-9261-9

Weitere Artikel der Ausgabe 6/2011

Inflammation 6/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.